Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreis, R.
Right arrow Articles by Ackerman, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreis, R.
Right arrow Articles by Ackerman, Z.

Radiology, Vol 182, 19-27, Copyright © 1992 by Radiological Society of North America


ARTICLES

Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy

R Kreis, BD Ross, NA Farrow and Z Ackerman
Magnetic Resonance Spectroscopy Laboratory, Huntington Medical Research Institute, Pasadena, CA 91105.

Proton magnetic resonance (MR) spectroscopy of the brain was performed in 11 patients with chronic hepatic encephalopathy (CHE), and the results were compared with those of patients with liver disease but without CHE; clinical control subjects with diabetes, uremia, or cortical atrophy; and healthy subjects. The technique of water- suppressed stimulated-echo hydrogen-1 MR spectroscopy for detection of cerebral glutamate, glutamine, glucose, N-acetylaspartate, choline metabolites, (phospho)creatine, and myo-inositol is described. Specific changes in the brain of CHE patients included the anticipated elevation in cerebral glutamine levels (P less than or equal to .0001), a 23% reduction in choline metabolite levels (P less than or equal to .0001), and a more than 50% reduction in cerebral myo-inositol levels (P less than or equal to .0001). In four of the 15 patients with liver disease but without clinical CHE, a significant reduction in the myo-inositol level was detected, and in two of these patients an elevation in the glutamine concentration was also observed. These findings indicate a role for image-guided H-1 MR spectroscopy in the diagnosis and monitoring of both overt and preclinical CHE.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A. Rovira, J. Alonso, and J. Cordoba
MR Imaging Findings in Hepatic Encephalopathy
AJNR Am. J. Neuroradiol., October 1, 2008; 29(9): 1612 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
Y.-C. Wong, W. L. Au, M. Xu, J. Ye, and C. C. T. Lim
Magnetic Resonance Spectroscopy in Adult-Onset Citrullinemia: Elevated Glutamine Levels in Comatose Patients
Arch Neurol, July 1, 2007; 64(7): 1034 - 1037.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W.-C. Shyu, S.-Z. Lin, M.-F. Chiang, C.-Y. Su, and H. Li
Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats.
J. Neurosci., March 29, 2006; 26(13): 3444 - 3453.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
W. K. Oakden, A. M. Moore, S. Blaser, and M. D. Noseworthy
1H MR Spectroscopic Characteristics of Kernicterus: A Possible Metabolic Signature
AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1571 - 1574.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. A. Page, C. A. Davie, D. MacManus, K. A. Miszkiel, J. M. Walshe, D. H. Miller, A. J. Lees, and A. H.V. Schapira
Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease
Neurology, August 24, 2004; 63(4): 638 - 643.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
P. R. Burkhard, J. Delavelle, R. Du Pasquier, and L. Spahr
Chronic Parkinsonism Associated With Cirrhosis: A Distinct Subset of Acquired Hepatocerebral Degeneration
Arch Neurol, April 1, 2003; 60(4): 521 - 528.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. R. Petrella, R. E. Coleman, and P. M. Doraiswamy
Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology, February 1, 2003; 226(2): 315 - 336.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. S. Shim, J. H. Lee, S. Y. Kim, T.-H. Lim, S. J. Kim, D. S. Kim, and W. D. Kim
Cerebral Metabolic Abnormalities in COPD Patients Detected by Localized Proton Magnetic Resonance Spectroscopy
Chest, November 1, 2001; 120(5): 1506 - 1513.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. W. Lee, J. H. Lee, T.-H. Lim, H. S. Yang, M.-K. Hong, J.-K. Song, S.-W. Park, S.-J. Park, and J.-J. Kim
Prognostic Significance of Cerebral Metabolic Abnormalities in Patients With Congestive Heart Failure
Circulation, June 12, 2001; 103(23): 2784 - 2787.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
C.-G. Choi and H. W. Yoo
Localized Proton MR Spectroscopy in Infants with Urea Cycle Defect
AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 834 - 837.
[Abstract] [Full Text]


Home page
RadiologyHome page
M. K. Lim, C. H. Suh, H. J. Kim, Y. K. Cho, S. H. Choi, J. H. Kang, W. Park, and J. H. Lee
Systemic Lupus Erythematosus: Brain MR Imaging and Single-Voxel Hydrogen 1 MR Spectroscopy
Radiology, October 1, 2000; 217(1): 43 - 49.
[Abstract] [Full Text]


Home page
NeurologyHome page
F. Jessen, W. Block, F. Traber, E. Keller, S. Flacke, A. Papassotiropoulos, R. Lamerichs, R. Heun, and H. H. Schild
Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD
Neurology, September 12, 2000; 55(5): 684 - 688.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. Naegele, W. Grodd, R. Viebahn, U. Seeger, U. Klose, D. Seitz, S. Kaiser, I. Mader, J. Mayer, W. Lauchart, et al.
MR Imaging and
Radiology, September 1, 2000; 216(3): 683 - 691.
[Abstract] [Full Text]


Home page
NeurologyHome page
K. Kantarci, C. R. Jack Jr., Y. C. Xu, N. G. Campeau, P. C. O'Brien, G. E. Smith, R. J. Ivnik, B. F. Boeve, E. Kokmen, E. G. Tangalos, et al.
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study
Neurology, July 25, 2000; 55(2): 210 - 217.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. W. Haley, W. W. Marshall, G. G. McDonald, M. A. Daugherty, F. Petty, and J. L. Fleckenstein
Brain Abnormalities in Gulf War Syndrome: Evaluation with
Radiology, June 1, 2000; 215(3): 807 - 817.
[Abstract] [Full Text]


Home page
GutHome page
R Jalan, N Turjanski, S D Taylor-Robinson, M J Koepp, M P Richardson, J A Wilson, J D Bell, and D J Brooks
Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis
Gut, April 1, 2000; 46(4): 546 - 552.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. W. Lee, J.-H. Lee, J.-J. Kim, S.-W. Park, M.-K. Hong, S.-T. Kim, T.-H. Lim, and S.-J. Park
Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1196 - 1202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Hirata, T. Kawaguchi, S. W. Brusilow, R. J. Traystman, and R. C. Koehler
Preserved hypocapnic pial arteriolar constriction during hyperammonemia by glutamine synthetase inhibition
Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H456 - H463.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
I. Trope, D. Lopez-Villegas, and R. E. Lenkinski
Magnetic Resonance Imaging and Spectroscopy of Regional Brain Structure in a 10-Year-Old Boy With Elevated Blood Lead Levels
Pediatrics, June 1, 1998; 101 (6): e7 - e7.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. LANG, G. L. BUSCH, M. RITTER, H. VOLKL, S. WALDEGGER, E. GULBINS, and D. HAUSSINGER
Functional Significance of Cell Volume Regulatory Mechanisms
Physiol Rev, January 1, 1998; 78(1): 247 - 306.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Lopez-Villegas, R. E. Lenkinski, and I. Frank
Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy
PNAS, September 2, 1997; 94(18): 9854 - 9859.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E A Jones and K Weissenborn
Neurology and the liver
J. Neurol. Neurosurg. Psychiatry, September 1, 1997; 63(3): 279 - 293.
[Full Text] [PDF]


Home page
RadiologyHome page
S. G. Cho, M. Y. Kim, H. J. Kim, Y. S. Kim, W. Choi, S. H. Shin, K. C. Hong, Y.-B. Kim, J. H. Lee, and C. H. Suh
Chronic Hepatitis: In Vivo Proton MR Spectroscopic Evaluation of the Liver and Correlation with Histopathologic Findings
Radiology, December 1, 2001; 221(3): 740 - 746.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1992 by the Radiological Society of North America.